Utilization of genomic signatures to identify phenotype-specific drugs
about
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathwayMDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cellsBreast cancer genomes--form and functionPredicting in vitro drug sensitivity using Random ForestsUsing a stem cell-based signature to guide therapeutic selection in cancer.Improving Drug Sensitivity Prediction Using Different Types of DataMetabolic Signatures of Human Breast Cancer.Using activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivityNovel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures.Behavioral screening for neuroactive drugs in zebrafish.Gene signature critical to cancer phenotype as a paradigm for anticancer drug discovery.Molecular Signatures of Radiation Response in Breast Cancer: Towards Personalized Decision-Making in Radiation Treatment.
P2860
Q24302433-9CFCE803-F481-4C88-9AC9-056466399A13Q31012806-5D782325-3FEB-40FB-B6C7-9ED4DA985FD1Q34207688-F8D392FE-81DD-40FA-9BDB-13AE78C4EA8EQ34480086-270FAF89-9C7A-4512-A130-B8456A5F5867Q34629979-C9881D06-B896-455E-B509-CE9157AF7A9AQ35179551-0EABF5B3-C809-4ECF-9285-58B514D77AB8Q35627478-94D2613D-55C6-40A2-8E9F-1ABACA8A2CDAQ36382520-336A7A51-EBD8-4713-B9F0-CF4E60331A22Q36580194-3A7205FE-637A-4AAC-A869-FB6D3C70C90BQ37875030-22DB6383-29F0-4400-BBD2-95CC4765DB80Q39975408-6458A855-5710-4FB6-8D8C-192564C5E251Q48214148-F908F8D9-1969-43AA-B5C3-F06CE7D5C080
P2860
Utilization of genomic signatures to identify phenotype-specific drugs
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Utilization of genomic signatures to identify phenotype-specific drugs
@ast
Utilization of genomic signatures to identify phenotype-specific drugs
@en
Utilization of genomic signatures to identify phenotype-specific drugs
@nl
type
label
Utilization of genomic signatures to identify phenotype-specific drugs
@ast
Utilization of genomic signatures to identify phenotype-specific drugs
@en
Utilization of genomic signatures to identify phenotype-specific drugs
@nl
prefLabel
Utilization of genomic signatures to identify phenotype-specific drugs
@ast
Utilization of genomic signatures to identify phenotype-specific drugs
@en
Utilization of genomic signatures to identify phenotype-specific drugs
@nl
P2093
P2860
P1433
P1476
Utilization of genomic signatures to identify phenotype-specific drugs
@en
P2093
Anil Potti
Jeffrey T Chang
Joseph R Nevins
Seiichi Mori
P2860
P356
10.1371/JOURNAL.PONE.0006772
P407
P577
2009-08-28T00:00:00Z